These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. [The role of M-VAC polychemotherapy in the treatment of advanced urothelial carcinoma of the bladder]. Stöckle M, Meyenburg W, Wellek S, Voges G, Gertenbach U, Thüroff JW, Huber C, Hohenfellner R. Ann Urol (Paris); 1993 Feb; 27(1):51-7. PubMed ID: 7682388 [Abstract] [Full Text] [Related]
31. Pre-cystectomy chemotherapy with sequentially administered cisplatin, cyclophosphamide and adriamycin in invasive transitional cell carcinoma of the bladder (preliminary report). Guazzieri S, Sperandio P, Fandella A, Garbeglio A, Pegoraro V, Chiarion V, Fiorentino M, Pagano F. Prog Clin Biol Res; 1988 Feb; 260():599-602. PubMed ID: 3362909 [No Abstract] [Full Text] [Related]
32. Treatment of high-stage bladder cancer: case for adjunctive chemotherapy. Walther PJ. Semin Urol; 1993 May; 11(2):69-73. PubMed ID: 8362122 [No Abstract] [Full Text] [Related]
33. Effect of recombinant human granulocyte colony-stimulating factor in patients receiving methotrexate/vinblastine/doxorubicin/cisplatin therapy for the treatment of transitional cell carcinoma of the urinary tract. Akaza H, Kotake T, Miyanaga N, Koiso K. Semin Oncol; 1994 Feb; 21(1 Suppl 1):70-4. PubMed ID: 7512280 [No Abstract] [Full Text] [Related]
35. [MEP (methotrexate, etoposide and cisplatin) and M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for advanced uroepithelial cancer--a preliminary report of MEP as second line chemotherapy for recurrence after M-VAC]. Seguchi T, Nakano E, Miki T, Kondoh M, Nishimura K, Nakamura N, Okuyama A. Gan To Kagaku Ryoho; 1994 Jan; 21(1):59-65. PubMed ID: 8291917 [Abstract] [Full Text] [Related]
36. [Neoadjuvant and adjuvant chemotherapy of bladder cancer]. Kuroda M, Kotake T. Gan To Kagaku Ryoho; 1994 Oct; 21 Suppl 3():362-9. PubMed ID: 7986116 [Abstract] [Full Text] [Related]
37. [Early clinical result of modified M-VAC (methotrexate, vinblastine, doxorubicin, and cisplatin) for advanced transitional cell carcinoma of renal pelvis and ureter]. Shishido S, Hayakawa M, Higa I, Koyama Y, Hatano T, Osawa A. Hinyokika Kiyo; 1990 Apr; 36(4):401-5. PubMed ID: 2378303 [Abstract] [Full Text] [Related]
38. Pre surgery chemotherapy in bladder cancer. Francini M, Veronesi A, Dal Bo V, Carbone A, Monfardini S. Prog Clin Biol Res; 1988 Apr; 260():585-9. PubMed ID: 3362908 [No Abstract] [Full Text] [Related]